INOVIQ Ltd - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Mesoblast (ASX: MSB) clears key treatment milestone ahead of mid-2027 back pain trial readout

Santos (ASX: STO) warns Australia’s 20% gas reservation rule could undermine GLNG economics

Russian missiles strike Kyiv as attacks injure 17 in Zaporizhzhia and Kharkiv

Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed

INOVIQ Ltd (ASX: IIQ) highlights its EXO-OC ovarian cancer screening breakthrough at ASCO 2025, achieving 77% sensitivity and 99.6% specificity.

Read More

Healthcare Industry News

INOVIQ (ASX: IIQ) soars on breakthrough ovarian cancer test data at ASCO 2025

INOVIQ Ltd (ASX: IIQ) stock surged 47.73% after ASCO 2025 data showed 77% sensitivity, 99.6% specificity in ovarian cancer screening. Explore what's next for EXO-OC.

byPallavi Madhiraju

June 2, 2025

web analytics